Effect of formoterol and budesonide on chemokine release, chemokine receptor expression and chemotaxis in human neutrophils.
Strandberg
Karin
K
Lung and Allergy Research, The National Institute of Environmental Medicine, Karolinska Institutet, Box 287, SE-171 77 Stockholm, Sweden. karin.strandberg@ki.se
Blidberg
Kristin
K
Sahlander
Karin
K
Palmberg
Lena
L
Larsson
Kjell
K
D000318:Adrenergic beta-Agonists / Q000494:pharmacology; D000328:Adult; D019819:Budesonide / Q000494:pharmacology*; D002465:Cell Movement / Q000187:drug effects; D054360:Chemokine CXCL1 / Q000187:drug effects / Q000378:metabolism; D002634:Chemotaxis, Leukocyte / Q000187:drug effects; D004983:Ethanolamines / Q000494:pharmacology*; D005260:Female; D000068759:Formoterol Fumarate; D005938:Glucocorticoids / Q000494:pharmacology; D006801:Humans; D066298:In Vitro Techniques; D015850:Interleukin-6 / Q000378:metabolism; D016209:Interleukin-8 / Q000187:drug effects / Q000378:metabolism; D008070:Lipopolysaccharides; D008297:Male; D008875:Middle Aged; D009504:Neutrophils / Q000187:drug effects* / Q000378:metabolism; D023062:Receptors, Interleukin-8A / Q000187:drug effects / Q000235:genetics; D023063:Receptors, Interleukin-8B / Q000187:drug effects / Q000235:genetics; D015854:Up-Regulation / Q000187:drug effects; D055815:Young Adult
D000318:Adrenergic beta-Agonists; D054360:Chemokine CXCL1; D004983:Ethanolamines; D005938:Glucocorticoids; D015850:Interleukin-6; D016209:Interleukin-8; D008070:Lipopolysaccharides; D023062:Receptors, Interleukin-8A; D023063:Receptors, Interleukin-8B; D019819:Budesonide; D000068759:Formoterol Fumarate